Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1450001
European Journal of Endocrinology, Vol 145, Issue 1, 1-9
Copyright © 2001 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ukkola, O
Right arrow Articles by Bouchard, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ukkola, O
Right arrow Articles by Bouchard, C

Articles

Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study

O Ukkola, J Gagnon, T Rankinen, PA Thompson, Y Hong, AS Leon, DC Rao, JS Skinner, JH Wilmore, and C Bouchard

Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA. ukkolao@pbrc.edu

OBJECTIVE AND METHODS: To investigate from the HERITAGE Family Study database, 13 steroid hormones (androstane-3alpha, 17beta-diol glucuronide, androsterone glucuronide, cortisol, dehydroepiandrosterone (DHEA), DHEA ester (DHEAE), DHEA sulfate (DHEAS), dihydrotestosterone (DHT), estradiol, 17-hydroxyprogesterone, progesterone, pregnenolone ester, sex hormone binding globulin (SHBG) and testosterone in each sex for their relationships with age, body mass index (BMI), race and key lifestyle variables. Sample sizes varied from 676 to 750 per hormone. Incremental regression methods were used to examine the contributions of the variables to steroid hormone variability. RESULTS: Age was a major predictor for most steroid hormones. The greatest contribution of age was a negative relationship with DHEAS (R(2)=0.39). BMI was also associated with the variability of several steroid hormones, being the most important predictor of SHBG (R(2)=0.20) and of testosterone (R(2)=0.12) concentrations. When age and BMI were included, race still contributed significantly to the variations in cortisol (R(2)=0.02 for men and 0.04 for women), DHT (R(2)=0.02 for men and 0.03 for women), and progesterone (R(2)=0.03 for women). Nevertheless, race appeared to be less important than age and BMI. In addition, lifestyle indicators (food and nutrient intakes, smoking and physical activity) influenced steroid hormone variability. Their contributions, however, were minor in most cases once age, BMI and race had been taken into account. CONCLUSIONS: We conclude that age was the most important factor, followed by BMI, race and lifestyle factors in explaining steroid hormone variability.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Rohrmann, C. G. Sutcliffe, J. L. Bienstock, D. Monsegue, F. Akereyeni, G. Bradwin, N. Rifai, M. N. Pollak, T. Agurs-Collins, and E. A. Platz
Racial Variation in Sex Steroid Hormones and the Insulin-Like Growth Factor Axis in Umbilical Cord Blood of Male Neonates
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1484 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Ziomkiewicz, P.T. Ellison, S.F. Lipson, I. Thune, and G. Jasienska
Body fat, energy balance and estradiol levels: a study based on hormonal profiles from complete menstrual cycles
Hum. Reprod., November 1, 2008; 23(11): 2555 - 2563.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. B. Spencer, M. Klein, A. Kumar, and R. Azziz
The Age-Associated Decline of Androgens in Reproductive Age and Menopausal Black and White Women
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4730 - 4733.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Crabbe, V. Bogaert, D. De Bacquer, S. Goemaere, H. Zmierczak, and J. M. Kaufman
Part of the Interindividual Variation in Serum Testosterone Levels in Healthy Men Reflects Differences in Androgen Sensitivity and Feedback Set Point: Contribution of the Androgen Receptor Polyglutamine Tract Polymorphism
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3604 - 3610.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Rohrmann, W. G. Nelson, N. Rifai, T. R. Brown, A. Dobs, N. Kanarek, J. D. Yager, and E. A. Platz
Serum Estrogen, But Not Testosterone, Levels Differ between Black and White Men in a Nationally Representative Sample of Americans
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2519 - 2525.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Guder, J. Bauersachs, S. Frantz, D. Weismann, B. Allolio, G. Ertl, C. E. Angermann, and S. Stork
Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure
Circulation, April 3, 2007; 115(13): 1754 - 1761.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Rodriguez, S. J. Freedland, A. Deka, E. J. Jacobs, M. L. McCullough, A. V. Patel, M. J. Thun, and E. E. Calle
Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 63 - 69.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
N van Montfoort, M J J Finken, S le Cessie, F W Dekker, and J M Wit
Could cortisol explain the association between birth weight and cardiovascular disease in later life? A meta-analysis
Eur. J. Endocrinol., December 1, 2005; 153(6): 811 - 817.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. P. Pinheiro, M. D. Holmes, M. N. Pollak, R. L. Barbieri, and S. E. Hankinson
Racial Differences in Premenopausal Endogenous Hormones
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2147 - 2153.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, et al.
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve {beta}-Cell Function: Report of an ADA Workshop, 21-22 October 2001
Diabetes, January 1, 2004; 53(1): 250 - 264.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Ukkola, T. Rankinen, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard
A Genome-Wide Linkage Scan for Steroids and SHBG Levels in Black and White Families: The HERITAGE Family Study
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3708 - 3720.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 European Society of Endocrinology.